<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04033718</url>
  </required_header>
  <id_info>
    <org_study_id>300003461</org_study_id>
    <nct_id>NCT04033718</nct_id>
  </id_info>
  <brief_title>Inpatient Package to Reduce HIV and AIDS-related Death in Zambia</brief_title>
  <acronym>IPADZ</acronym>
  <official_title>Inpatient Package to Reduce HIV and AIDS-related Death in Zambia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Maryland, College Park</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early post-discharge mortality is high among HIV-infected Zambians admitted to the hospital.
      Likely this is in part due to missed opportunities to identify lethal coinfections and
      optimize HIV care during admission (and before discharge). In this study the investigators
      will develop and pilot a new approach to inpatient HIV care that follows international
      guidelines for management of advanced HIV disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 28, 2020</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Coinfection diagnosis</measure>
    <time_frame>Through hospital discharge, an average of 2 weeks</time_frame>
    <description>Positive test for tuberculosis or cryptococcus on admission</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">319</enrollment>
  <condition>HIV/AIDS</condition>
  <condition>Transitions of Care</condition>
  <condition>Hospitalization</condition>
  <condition>Tuberculosis</condition>
  <condition>HIV Testing</condition>
  <arm_group>
    <arm_group_label>Inpatient testing package</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing for CD4 count, tuberculosis, cryptococcus, and HIV RNA</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Inpatient testing package</intervention_name>
    <description>The investigators will provide patients a package of diagnostic tests at the time of admission to comprehensively assess for HIV coinfections and treatment failure</description>
    <arm_group_label>Inpatient testing package</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18+ years old

          -  HIV-positive (by self-report or DCT result in UTH file)

          -  Resident of Lusaka urban district.

        Exclusion Criteria:

          -  Too sick to provide informed consent (based on clinician opinion)

          -  Likely to be discharged in the next 48 hours (based on clinician opinion)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Vinikoor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael J Vinikoor, MD</last_name>
    <phone>8479025400</phone>
    <email>mjv3@uab.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jamie White</last_name>
    <phone>2059348145</phone>
    <email>jamiewhite@uabmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Teaching Hospital</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lottie Hachaambwa, MBChB</last_name>
      <phone>+260 976435603</phone>
      <email>lhachaambwa@ihv.umaryland.edu</email>
    </contact>
    <contact_backup>
      <last_name>Michael Vinikoor, MD</last_name>
      <phone>+260 972921285</phone>
      <email>mjv3@uab.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Zambia</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 23, 2019</study_first_submitted>
  <study_first_submitted_qc>July 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2019</study_first_posted>
  <last_update_submitted>April 1, 2020</last_update_submitted>
  <last_update_submitted_qc>April 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Michael Vinikoor</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

